Skip to main content

About us
About Blood Cancer United

Who we are

Financials

Leadership

DEI/Health equity commitment

Careers

Contact us
Featured programs

The Dare to Dream Project

Light The Night
Partners and suppliers

Corporate partnerships

Give for More Life

Supplier resources
Stories and news

Our stories

Newsroom

Blog
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Financial assistance
Financial support

Explore all assistance programs

Patient Aid Program

Co-Pay Assistance Program

Local Financial Assistance Program

Patient Travel Assistance Program

Pre-CAR T-cell Therapy Travel Assistance Program

Urgent Need Programs
Additional financial assistance

Medical Debt Case Management Program

Scholarships for Blood Cancer Survivors

Veterans Dental Partnership

Other financial assistance
Claims

Track your claim
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Advocacy
Policy and advocacy

Overview

What does the Office of Public Policy do?
Featured efforts

Making treatment affordable for patients

Improving the quality of health insurance

Making clinical trials work for patients

Cost of cancer care

Advocating for pediatric patients and survivors

Ensuring medicaid is available and stable

Accelerating progress in cancer R&D
Sign up now

Be an advocate

Join the Mobile Action Network
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Local groups
Careers
En Español

Donate now Cart is empty

Blood cancers

Types of blood cancer

Leukemia
Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Hairy cell leukemia (HCL) Chronic myelomonocytic leukemia (CMML) Juvenile myelomonocytic leukemia (JMML) Large granular lymphocytic (LGL) leukemia Blastic plasmacytoid dendritic cell neoplasm (BPDCN) B-cell prolymphocytic leukemia (B-PLL) T-cell prolymphocytic leukemia (T-PLL)

Lymphoma
Non-Hodgkin lymphoma (NHL) Hodgkin lymphoma

Myeloma

Myelodysplastic syndromes (MDS)

Myeloproliferative neoplasms (MPNs)
Essential thrombocythemia (ET) Myelofibrosis (MF) Polycythemia vera (PV)

Blood cancer facts and statistics

Leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) are types of cancer that can affect the bone marrow, the blood cells, the lymph nodes, and other parts of the lymphatic system.

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Navigating your care

Navigate care by patient type

Adults
Working with your care team Treatment options Know your rights, manage your finances Managing daily life After treatment

Young adults
Working with your care team Treatment options Know your rights, manage your finances Managing daily life After treatment

Children and teens
Working with your child's care team Coping with a child's diagnosis Know your rights, manage your finances Caring for your child during treatment After treatment

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Resources

Resources

Patient resources

Caregiver resources

Healthcare professional resources

Educational resources
Publications Webcasts/Videos Blood cancer conferences 3D Model Library

Support resources
Information Specialists Clinical Trial Support Center (CTSC) Registered Dietitians Online chats Support groups Peer-to-peer support Patient Community Podcasts Health Manager mobile app Registry Other helpful organizations

Newsroom
Blog Suggested reading

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Research

Research

Who we fund

Research we fund

Impact on research progress

Research Grant Programs

Therapy Acceleration Program® (TAP)

TAP portfolio

TAP How to Apply

Beat AML®

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Get involved

Get involved

Ways to donate
Donor-advised funds Honor and memorial gifts Monthly giving Cryptocurrency Stock gifts Wills, annuities, and other planned gifts Real estate gifts Workplace giving Employee matching gifts

Ways to volunteer
Volunteer Portal Volunteer Grants

Fundraising
Athletic Events America's Most Beautiful Bike Ride Big Climb Climb 2 Cure DIY fundraiser Firefighter Stairclimb Light The Night Scenic Shore Bike Tour Shred for Red Visionaries of the Year Student Visionaries of the Year Velo Palmetto

Policy and advocacy

Shop

College Campus Clubs

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat

Donate now

Search

Popular Keywords

Financial Assistance Leukemia Support Treatments Ways to Support

Talk to Information Specialist
+1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat

Home

Search Results

Filter Results

12473 results for

Refine Your Search

HOSA - Volunteer Hosted Walk

HOSA- Volunteer Hosted Walk

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Tulsa

Tulsa

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Oklahoma City

Tarrant County

Tarrant County

Tarrant County

Tarrant County

Tarrant County

Tarrant County

Tarrant County

Tarrant County

Little Rock

Little Rock

Little Rock

Little Rock

Russellville

Russellville

NW Arkansas

NW Arkansas

Previous page
page 1
...
Page 433
Current page 434
Page 435
...
page 499
Next

Previous
Next

Refine your search

Sort by

Disease Type

Leukemia (866)

Lymphoma (701)

Myeloma (462)

Acute Myeloid Leukemia (AML) (396)

Acute Lymphoblastic Leukemia (ALL) (334)

Other Blood Cancers (278)

Non-Hodgkin Lymphoma (NHL) (251)

Myelodysplastic Syndromes (MDS) (239)

Hodgkin Lymphoma (HL) (235)

Myeloproliferative Neoplasms (MPN) (208)

Chronic Lymphocytic Leukemia (CLL/SLL) (102)

Chronic Myeloid Leukemia (CML) (88)

Diffuse Large B-cell Lymphoma (DLBCL) (62)

Juvenile Myelomonocytic Leukemia (JMML) (50)

Follicular Lymphoma (FL) (47)

Mantle Cell Lymphoma (MCL) (37)

Hairy Cell Leukemia (HCL) (29)

Acute promyelocytic leukemia (APL) (25)

Polycythemia Vera (23)

Waldenström Macroglobulinemia (WM) (23)

Chronic Myelomonocytic Leukemia (CMML) (22)

Primary Myelofibrosis (22)

Essential Thrombocythemia (20)

Chronic Lymphocytic Leukemia/Small-cell Lymphocytic Lymphoma (CLL/SLL) (18)

Burkitt Lymphoma (BL) (16)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (13)

Large B-Cell Lymphoma (LBCL) (13)

Marginal Zone Lymphoma (MZL) (13)

Adult T-cell Leukemia/Lymphoma (11)

Myeloma-related Amyloidosis (11)

Cutaneous T-cell Lymphoma (CTCL) (10)

Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS) (9)

T-Cell Prolymphocytic Leukemia (9)

B-Cell Prolymphocytic Leukemia (8)

Large Granular Lymphocytic Leukemia (LGL) (8)

Plasma Cell Leukemia (8)

Chronic Eosinophilic Leukemia (7)

POEMS Syndrome (7)

Extranodal Natural Killer (NK)/T-cell Lymphoma (ENK/TCL), nasal type (6)

High-grade B-cell Lymphoma with double or triple hits (HBL) (6)

Lymphoblastic Lymphoma (6)

Angioimmunoblastic T-cell Lymphoma (AITL) (5)

MDS Primary (5)

Primary Mediastinal (Thymic) Large B-cell Lymphoma (PMBCL) (5)

Hepatosplenic T-cell Lymphoma (4)

MPAL (4)

Nodal Marginal Zone Lymphoma (NMZL) (4)

Primary Central Nervous System (CNS) Lymphoma (4)

Systemic Anaplastic Large-cell Lymphoma (ALCL) (4)

Acquired Immunodeficiency Syndrome (AIDS)-associated Lymphoma (3)

Chronic Neutrophilic Leukemia (3)

Enteropathy-associated Intestinal T-cell Lymphoma (3)

Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma (3)

MD Secondary (3)

Primary Cutaneous Anaplastic Large-cell Lymphoma (pcALCL) (3)

Primary Cutaneous DLBCL, leg type (3)

Primary DLBCL of the central nervous system (3)

Prolymphocytic Leukemia (3)

Splenic Marginal Zone Lymphoma (SMZL) (3)

Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL) (3)

Transformed Follicular and Transformed Mucosa-associated Lymphoid Tissue (MALT) Lymphomas (3)

Lymphoplasmacytic Lymphoma (2)

MDS/MDP Overlap (2)

Constituent Type

All Audiences (445)

Patient: Adult (261)

Patient: Young Adults (241)

Caregiver (238)

Patient: Children and Teens (221)

Adults (162)

Research (73)

Teens & Children (51)

Young Adult (34)

Policy/Advocate (32)

Healthcare Professional (28)

Donor/Fundraiser (16)

Sponsor (5)

Partner (4)

Volunteer (4)

LGBTQIA+ (2)

Other (2)

Other Organizations (2)

Region (1)

Survivor (1)

Media type

Event (7445)

Article (1195)

Inspirational Stories (1069)

Partner Organization (383)

Support Resource (343)

Grant (337)

Booklet (333)

Grant Recipient (303)

Video (194)

Drug (163)

Suggested reading (146)

Blog (143)

Mission (126)

Basic Page (122)

Landing Page (111)

Marketing Page (60)

Popular Keywords

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.

Get connected, stay informed

Call an Information Specialist

Highly trained oncology social workers and nurses.

+1-800-955-4572

(Monday–Friday 9 a.m.–9 p.m. ET)

Live chat | Email

Donate

Your donation supports groundbreaking research and vital patient services.

+1-888-557-7177

(Monday–Friday 9:30 a.m.–5:00 p.m. ET)

More ways to give.

Contact us
Privacy Policy (PDF*)
Consumer Health Data Privacy Policy (PDF*)
Security (PDF*)
Copyright (PDF*)
Link Policy (PDF*)
Website terms of use (PDF*)
Financial transparency and independence (PDF*)
Fundraising disclosure (PDF*)
Refund Policy (PDF*)
Community guidelines (PDF*)
Accessibility statement (PDF*)
Sweepstakes Rules (PDF)
LLS Canada
^{*Bilingual content/Contenido bilingüe}

Follow us

The Blood Cancer United mission: Cure blood cancer and improve the quality of life of all patients and their families. Blood Cancer United funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Blood Cancer United is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions. Tax Identification Number: 13-5644916

© Copyright 2015-2025 Blood Cancer United. A 501(c)(3) organization. All rights reserved.